Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

Along the obesity pandemic, the prevalence of non-alcoholic fatty liver disease (NAFLD), often regarded as the hepatic manifestation of the metabolic syndrome, increases worldwide representing now the prevalent liver disease in western countries. No pharmacotherapy is approved for the treatment of N...

Full description

Saved in:
Bibliographic Details
Published in:Front Endocrinol (Lausanne)
Main Authors: Seghieri, Marta, Christensen, Alexander S., Andersen, Andreas, Solini, Anna, Knop, Filip K., Vilsbøll, Tina
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2018
Subjects:
Endocrinology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6232120/
https://ncbi.nlm.nih.gov/pubmed/30459715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00649
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items